NCT00839670

Brief Summary

The purpose of this trial is to compare the effect of a modified constraint induced therapy to the treatment described originally by Taub et al.. This study will determine if LICITE will lead to similar improvements than the original described method.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at below P25 for phase_3 stroke

Timeline
Completed

Started Feb 2009

Shorter than P25 for phase_3 stroke

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 9, 2009

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

January 10, 2012

Status Verified

February 1, 2009

Enrollment Period

1.7 years

First QC Date

February 6, 2009

Last Update Submit

January 9, 2012

Conditions

Keywords

1- Constraint induced therapy2- Stroke3- Upper limb4- Rehabilitation5- Motor training1- First time clinical ischemic or hemorrhagic stroke2- At least 10° of active wrist extension3- At least 10° of thumb abduction/ extension4- At least 10° of extension in at least 2 additional digits3- Adequate balance while wearing the restraint.

Outcome Measures

Primary Outcomes (1)

  • Motor activity log scale

    10 days before inclusion, 10 days and 3 months after treatment achievement

Secondary Outcomes (1)

  • Wolf Motor Function test Stroke impact scale Functional MRI HAD scale

    10 days before inclusion, 10 days and 3 months after treatment achievement except for fMRI (no evaluation at 3 month)

Study Arms (2)

Modified Therapy

ACTIVE COMPARATOR
Other: Light constraint induced therapy

Standard Therapy

ACTIVE COMPARATOR
Other: Standard constraint induced therapy

Interventions

90 minutes of motor training with a physical or occupational therapist and 270 minutes of self-rehabilitation, 5 days/week/2 weeks.

Also known as: Modified constraint induced therapy
Modified Therapy

360 minutes of motor training with a physical or occupational therapist, 5 days/week/2 weeks

Also known as: Constraint induced therapy
Standard Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • First ischemic or hemorrhagic stroke between 2 and 12 months
  • at least 10°of active wrist extension and at least 10° of thumb abduction/ extension, and at least 10° of extension in at least 2 additional digits.
  • adequate balance while wearing the restraint

You may not qualify if:

  • Major cognitive impairment
  • Prior stroke
  • Excessive fatigability
  • Severe aphasia
  • MAL score ≥ 2,5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Médecine Physique et de Réadaptation - Hôpital BICHAT

Paris, Paris Cedex 18, 75877, France

Location

MeSH Terms

Conditions

StrokeHemorrhagic Stroke

Interventions

Constraint Induced Movement Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Olivier SIMON, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2009

First Posted

February 9, 2009

Study Start

February 1, 2009

Primary Completion

November 1, 2010

Study Completion

June 1, 2011

Last Updated

January 10, 2012

Record last verified: 2009-02

Locations